ClinConnect ClinConnect Logo
Search / Trial NCT07023874

Dexmedetomidine Combined With Bupivacaine in Ultrasound-guided Pecto-Intercostal Fascial Block in Cardiac Surgery

Launched by ALEXANDRIA UNIVERSITY · Jun 14, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Pectointercostal Fascial Plain Block Dexmedetomidine

ClinConnect Summary

This clinical trial is looking at a new way to help manage pain after heart surgery. It focuses on a technique called the pecto-intercostal fascial plane block (PIFPB), where a local numbing medicine is carefully placed near certain chest muscles using ultrasound guidance. This helps numb the nerves that carry pain signals from the chest area, especially around the breastbone. The study is testing whether adding a medicine called dexmedetomidine can make the pain relief stronger and last longer after surgery.

Adults aged 18 to 60 who are scheduled for planned heart surgery using a heart-lung machine may be able to join this study. To participate, patients should be in generally stable health (classified as ASA II or III) and not have serious liver, kidney, or heart failure problems. People with allergies to the study medicines, those who have had previous chest surgeries, or those who use long-term pain medications would not be eligible. If you take part, you can expect to receive the nerve block during your surgery to help control pain afterward, with the goal of making recovery more comfortable and possibly speeding up your healing process.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age 18-60 years.
  • 2. Both sexes.
  • 3. ASA physical status class II or III.
  • 4. Elective fast-tracking on-pump cardiac surgery.
  • Exclusion Criteria:
  • 1. The patient refused to participate in the study.
  • 2. Cognitive impairment or mental disorders.
  • 3. Hepatic and renal impairment.
  • 4. Congestive heart failure.
  • 5. Urgent/emergent surgery.
  • 6. BMI \<18 and \>35 (kg/m2).
  • 7. Documented allergy to local anaesthetics or dexmedetomidine.
  • 8. Use of chronic pain medications.
  • 9. Previous sternotomy or chest surgery.
  • 10. Patients with a history of substance abuse.
  • 11. Requires the use of mechanical circulatory support pre-operatively.
  • 12. Patients who will not be candidates for fast-tracking extubation after block administration.

About Alexandria University

Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.

Locations

Patients applied

0 patients applied

Trial Officials

LECTURER OF ANESTHESIA AND SURGICAL INTENSIVE CARE

Principal Investigator

University of Alexandria

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported